Monash IVF Group (ASX:MVF) Updates FY25 Profit Guidance
Monash IVF Group (ASX:MVF) revises FY25 Underlying NPAT guidance to $27.5m, reflecting softer market conditions.
Category: ASX-MVF
Monash IVF Group Limited
Latest News
360 Capital Mortgage REIT (ASX:TCF) Secures New Loans and Extends Existing Facility
Kingston Resources Limited (ASX:KSN) Divests Misima Project for $95 Million
Terrain Minerals (ASX:TMX) Commences High-Grade Gold & Silver Drilling
Spacetalk Ltd (ASX:SPA) Announces Q3 and H1 FY25 Financial Results
Worley Limited (ASX:WOR) Reaffirms FY25 Outlook at Investor Day
Brazilian Rare Earths Limited (ASX:BRE) Secures Strategic Partnership with SENAI CIMATEC
Zoono Group Limited (ASX:ZNO) Secures Exclusive UK Packaging Agreement
Chimeric Therapeutics (ASX:CHM) Announces $6.6 Million Placement to Advance Clinical Trials
Monash IVF Group (ASX:MVF) Updates FY25 Profit Guidance
Noxopharm Limited (ASX:NOX) Raises $2.5 Million from Nyrada Share Sale
The Hub of Australian Finance News